Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Yoshifumi Watazu is active.

Publication


Featured researches published by Yoshifumi Watazu.


Bioscience, Biotechnology, and Biochemistry | 2000

The characteristics and applications of recombinant cholesterol dehydrogenase.

Koji Kishi; Yoshifumi Watazu; Yoshiaki Katayama; Hiroaki Okabe

Mass production of an r-CDH derived from Nocardia species was made possible by gene technology. (Horinouchi et al., Applied and Environmental Microbiology, 57, 1386-1393 (1991)). However, the characteristics of the r-CDH have not been studied in detail and have not been improved enough for industrial use. We accordingly characterized both the native-CDH and the r-CDH prepared from Streptomyces lividans. Both CDHs were monomers with molecular masses of 37 kDa. The K m of r-CDH was 2.50×10-3 M for cholesterol and 2.33×10-4 M for NAD. The activators of CDHs were TritonX-100 and cholate. TritonX-405, Ag+, and Zn2+ inhibited both enzymes. The residual activity of native CDH after heat treatment was 32% (37°C, 60 min), while the r-CDH showed a residual activity of 87% (37°C, 60 min). The r-CDH is an enzyme with high substrate specificity for cholesterol as well as native CDH and higher thermal stability than native CDH. We have developed a novel serum cholesterol assay using the r-CDH, which permits the direct measurement of cholesterol by measuring NADH reaction products. We conclude that this r-CDH enzyme is useful and can be used to measure cholesterol in a clinical chemistry setting.


Clinical Biochemistry | 1990

Proteolytic measurement of mitochondrial aspartate aminotransferase in human serum

Yoshifumi Watazu; Hiroaki Okabe; Hiroyuki Sugiuchi; Yoshinori Uji; Yasushi Shirahase; Nobuaki Kaneda

A new proteolytic measurement of serum mitochondrial aspartate aminotransferase was evaluated using cytosolic aspartate aminotransferase inactivating protease. Some of the proteases, such as, alpha-chymotrypsin, subtilisin and cytosolic aspartate aminotransferase inactivating protease 401 from Streptomyces species, also specifically inactivated cytosolic aspartate aminotransferase, but not mitochondrial, aspartate aminotransferase. The protease 401 was the most heat stable for storage and showed a higher inactivation rate for cytosolic aspartate aminotransferase--up to 7000 IU/L--more than 200-fold the upper limit. The coefficient of variation of the proteolytic method was less than 10%. Results by the present method correlated with those by the immunochemical method (r = 0.970) and the regression curve was Y = 0.95X + 1.60 (Y: immunochemical method; X: proteolytic method). In the present assay system, reference values for mitochondrial aspartate aminotransferase activity in 500 healthy people ranged from 2.0-7.2 U/L (mean 3.8 U/L).


Archive | 1998

Method for assaying biological specimens for substances contained in the components thereof and reagent to be used in this method

Koji Kishi; Tsutomu Kakuyama; Yasushi Shirahase; Yoshifumi Watazu


Archive | 1992

Method for highly sensitive determination of NADH using kinase

Tsuyoshi Ohno; Masaru Suzuki; Tatsuo Horiuchi; Yasushi Shirahase; Koji Kishi; Yoshifumi Watazu


Journal of Clinical Laboratory Analysis | 1993

Proteinase K inactivation of cytosolic aspartate aminotransferase isoenzyme for measurement of human serum mitochondrial aspartate aminotransferase

Yoshifumi Watazu; Yoshinori Uji; Hiroaki Okabe; Yasushi Shirahase; Nobuaki Kaneda; Arthur Karmen


Archive | 1990

GOT isozyme assay

Yasushi Shirahase; Yoshifumi Watazu


Bioscience, Biotechnology, and Biochemistry | 1994

Isolation and characterization of a serine proteinase, inactivating m-subunit of lactate dehydrogenase, from Penicillium citrinum KE-1.

Yoshifumi Watazu; Katashi Nagamatsu; Yasushi Shirahase; Nobuaki Kaneda; Sawao Murao; Hiroaki Okabe


Journal of Clinical Laboratory Analysis | 1990

Optimal conditions for protease use in the assay of serum mitochondrial aspartate aminotransferase

Hiroaki Okabe; Yoshinori Uji; Hiroyuki Sugiuchi; Yoshifumi Watazu; Yasushi Shirahase; Nobuaki Kaneda


Archive | 1999

Method for stabilizing enzymes and enzyme compositions

Toshiyuki Baba; Hiromasa Tabata; Katashi Nagamatsu; Yoshifumi Watazu; Ryoji Aoki


Archive | 1999

Methode de stabilisation d'enzymes et compositions enzymatiques

Toshiyuki Baba; Hiromasa Tabata; Katashi Nagamatsu; Yoshifumi Watazu; Ryoji Aoki

Collaboration


Dive into the Yoshifumi Watazu's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Arthur Karmen

Albert Einstein College of Medicine

View shared research outputs
Researchain Logo
Decentralizing Knowledge